Status:
UNKNOWN
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients
Lead Sponsor:
Assiut University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-70 years
Brief Summary
The aim of this study is to evaluate the role of miRNA 125a -5p and miRNA143-3p as a non invasive biomarker in diagnosis of breast cancer and the relationship between MiRNA expression and histopatholo...
Detailed Description
Breast cancer ( BC) is the most commonly diagnosed cancer in women worldwide. The incidence and mortality rates for female breast cancer far exceeded those for other cancers . Although the incidence r...
Eligibility Criteria
Inclusion
- control group of normal healthy individuals who don't have tumors in other organs.
- breast cancer group Patients with confirmed breast cancer who didn't receive radiotherapy ,chemotherapy ,hormonal therapy or surgical treatment.
Exclusion
- Patients refuse to be part of study and undergo examination .
- All patients with breast cancer that had received chemotherapy, radiotherapy , ,hormonal or surgical treatment.
- History of benign or malignant tumors in other organs
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04778202
Start Date
March 1 2022
End Date
March 1 2024
Last Update
March 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.